Research Program: Cancer Discovery Platforms Bridging the Engineering-Biology Continuum
Strategic Theme: Drug Discovery
David Sarlah is an organic chemist, using the discovery of new reactivities and the guiding principles of chemistry to aid in the creation of cancer therapies. Through collaborations with CCIL members, Sarlah has successfully developed several enabling methodologies and translated them into the efficient synthesis of anticancer natural products.
Sarlah received his undergraduate degree in chemistry from the University of Ljubljana in 2006 and his PhD from the Scripps Research Institute in 2011. Following a postdoctoral stay at ETH Zürich, he joined the faculty at Illinois in 2014. He currently serves as an Assistant Professor in the Department of Chemistry.